Search

GlaxoSmithKline PLC

Cerrado

SectorSalud

1,389.5 -0.22

Resumen

Variación precio

24h

Actual

Mínimo

1378.5

Máximo

1397

Métricas clave

By Trading Economics

Ingresos

559M

501M

Ventas

105M

8.1B

P/B

Media del Sector

21.557

57.333

BPA

23.2

Rentabilidad por dividendo

4.79

Margen de beneficio

6.172

Empleados

68,629

EBITDA

-52M

1.1B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+13.6% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

4.79%

2.63%

Próximas Ganancias

30 abr 2025

Fecha Próximo Dividendo

10 jul 2025

Próxima Fecha de Ex Dividendo

15 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-5.9B

54B

Apertura anterior

1389.72

Cierre anterior

1389.5

GlaxoSmithKline PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 abr 2025, 09:39 UTC

Principales Movimientos del Mercado

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

5 feb 2025, 11:32 UTC

Ganancias

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook -- 2nd Update

5 feb 2025, 08:56 UTC

Ganancias

Correction to GSK Article

5 feb 2025, 08:24 UTC

Ganancias

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After Beating Market Views -- Update

5 feb 2025, 07:43 UTC

Ganancias

GSK Expects Further Profit Growth After Beating Market Views

23 abr 2025, 21:48 UTC

Principales Noticias

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 abr 2025, 20:47 UTC

Principales Noticias

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 abr 2025, 20:40 UTC

Principales Noticias

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

15 abr 2025, 09:55 UTC

Charlas de Mercado

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 abr 2025, 07:23 UTC

Charlas de Mercado

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 abr 2025, 08:41 UTC

Charlas de Mercado

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 abr 2025, 08:36 UTC

Charlas de Mercado

U.K. Pharma to Have Some Share-Price Volatility But Long-Term Outlook Remains Intact -- Market Talk

3 abr 2025, 07:51 UTC

Charlas de Mercado

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

2 abr 2025, 09:27 UTC

Acciones populares

Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

26 mar 2025, 22:29 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mar 2025, 19:19 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mar 2025, 17:39 UTC

Principales Noticias

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

19 mar 2025, 14:50 UTC

Principales Noticias

HIV Drug Makers Get Spooked by Trump Cuts, but Impact Looks Manageable -- Heard on the Street -- WSJ

17 mar 2025, 09:00 UTC

Principales Noticias

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

24 feb 2025, 07:05 UTC

Adquisiciones, fusiones, absorciones

GSK Completes Acquisition of IDRx

14 feb 2025, 11:38 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb 2025, 11:30 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb 2025, 15:33 UTC

Charlas de Mercado
Ganancias

GSK's Pipeline Has to Prove It Can Counter Concerns Over Vaccine Business -- Market Talk

5 feb 2025, 08:38 UTC

Charlas de Mercado
Ganancias

GSK Needs to Show It Can Navigate Vaccines Challenge -- Market Talk

5 feb 2025, 07:05 UTC

Ganancias

GSK PLC Had Seen 2031 Sales Outlook at More Than GBP38B

5 feb 2025, 07:04 UTC

Ganancias

GSK PLC Sees 2031 Sales Outlook at More Than GBP40B

5 feb 2025, 07:03 UTC

Ganancias

GSK PLC Sees 2025 Adjusted EPS Growth of 6%-8%

5 feb 2025, 07:03 UTC

Ganancias

GSK PLC Raises Mid-Term View

5 feb 2025, 07:03 UTC

Ganancias

GSK PLC Sees 2025 Adjusted Operating Growth of 6% - 8%

5 feb 2025, 07:02 UTC

Ganancias

GSK PLC Sees 2025 Turnover Growth of 3% to 5%

GlaxoSmithKline PLC Esperado

Precio Objetivo

By TipRanks

13.6% repunte

Estimación a 12 meses

Media 1,583.64 GBX  13.6%

Máximo 2,290 GBX

Mínimo 1,350 GBX

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GlaxoSmithKline PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

11 ratings

1

Comprar

8

Mantener

2

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.